Original ArticlesThe Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma
Key words
Cited by (0)
Disclosure: T.D.C. has received support to attend the World Conference on Lung Cancer 2013 from Boehringer Ingelheim. H.D. has received a Postdoctoral Cancer Research Fellowship from the Cancer Council of Victoria. V.S. reports her institution received funding to pay for statistical advice related to this manuscript and has provided consultancy services to the Victorian Department of Health. M.M.M. received a grant from the St. Vincent’s Hospital research endowment fund. G.M.W. reports his institution receives funding from Covidien for educational presentations, his institution has previously received a grant from Covidien, and he has previously received funding for meeting expenses from Karl Storz. Funding for this study was provided by St. Vincent’s Hospital research endowment fund. T.D.C. was supported by Australian Postgraduate Award from the University of Melbourne. G.M.W. was supported by National Health and Medical Research Council Scholarship GNT 1038699 and University of Melbourne Medical Postgraduate Committee Gordon-Taylor Scholarship. All other authors declare no conflict of interest.